Founded in 2014 and headquartered in France, Coave Therapeutics recently received a grant investment on 16 February 2024 from The ALS Association. The company operates in the biotechnology and life sciences industries, with a vision to bring hope to patients with rare diseases through pioneering gene therapies.
Coave Therapeutics
Coave therapeutics new brand for Horama
Founded 2014
France
36 employees
Grant
Total: $79.10M
Biotechnology, Life Sciences
France
36 employees
Grant
Total: $79.10M
Biotechnology, Life Sciences
General Information
Company Name
Coave Therapeutics
Founded Year
2014
Location
France
France
Founders / Decision Makers
Employees
36
Industries
Biotechnology, Life Sciences
Funding Stage
Grant
Social
BounceWatch is an independent company data service, not affiliated with Coave Therapeutics. To contact Coave Therapeutics, visit coavetx.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Coave Therapeutics compare?
A PDF of Coave Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Coave Therapeutics soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Coave Therapeutics on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
France Market
Biotechnology
About Coave Therapeutics
Business keywords: gene therapy, ophthalmic disorders, CNS disorders, rare diseases, clinical stage company, AAV-Ligand Conjugates technology, ALIGATER platform, gene transduction, tissue distribution, unmet medical needs
Funding Rounds & Investors (7)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | Undisclosed | 1 |
The ALS Association
|
16 Feb 2024 |
| Series B | €33.00M | 8 |
|
21 Jul 2021 |
| Series B | €22.50M | 1 |
|
18 Sep 2018 |
| Series B | €19.00M | 7 |
|
08 Nov 2017 |
| Series A | €4.00M | - |
|
15 Nov 2016 |
| Grant | €150.00K | - |
|
01 Jul 2015 |
| Seed Round | €450.00K | 1 |
|
01 Jan 2015 |
Coave Therapeutics Alternatives & Competitors
View All Alternatives
Coave Therapeutics vs
Taysha Gene Therapies
United States
Taysha Gene Therapies is focused on advancing AAV-based gene therapies for severe monogenic diseases...
IPO
134 employees
Biotechnology, Life Sciences
Coave Therapeutics vs
Hopewell Therapeutics, Inc.
United States
Enabling a new generation of genomic medicines for patients with high unmet medical needs.
Seed
13 employees
Biotechnology, Health Care
Coave Therapeutics vs
We walk from obstacle to obstacle without loss of enthusiasm. 我们是从一个障碍走向另一个障碍而不丧失...
Series C
45 employees
Biotechnology, Life Sciences
Apic Bio
FAQ About Coave Therapeutics
Coave therapeutics new brand for Horama
Coave Therapeutics was founded in 2014.
Coave Therapeutics is headquartered in France.
Coave Therapeutics operates in Biotechnology and Life Sciences. Its work centres on gene therapy, ophthalmic disorders, CNS disorders and rare diseases.
Coave Therapeutics has approximately 36 employees.
Coave Therapeutics has completed 7 funding rounds, raising a total of $79.10M. The latest funding stage is Grant.
Top alternatives and competitors to Coave Therapeutics include Taysha Gene Therapies, Hopewell Therapeutics, Inc., Neurophth Therapeutics / 纽福斯生物科技有限公司, TransThera | 药捷安康, Lexeo Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Coave Therapeutics and Taysha Gene Therapies are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for Coave Therapeutics, https://bouncewatch.com/company/coave-therapeutics, updated 24 October 2024. When citing, please name BounceWatch and link this page.
